This conference series brings together senior thought leaders from across multiple disciplines to discuss strategies, technologies and capabilities that accelerate biopharmaceutical development. This year’s program will focus on artificial intelligence, sustainability, and novel process technology development tools that span drug substance and drug products. Explore the transformative potential of patient-centric drug delivery systems as high concentration biologics become increasingly prevalent.
New strategies that minimize environmental impact, optimize resource use, and promote green practices benefitting the planet are driving biopharma sector to invest differently. AccBio 2025 is not just an event, it’s a gathering of industry leaders who are driving change and igniting new ideas.
Poster Submission Deadline Extended: February 18, 2025
Early Bird Deadline: February 18, 2025
Join us to explore how AI is revolutionizing biomanufacturing with cutting edge innovations that enhance efficiency, reduce costs, and improve product quality.
I am eagerly looking forward to listening and discussing strategies and tools with our distinguished speakers that will help us achieve acceleration and bring more medicines to our patients.